Amanda Cushing, MSW, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 26 Cedar Lane, Danville, VT 05828 Phone: 802-684-2275 |
News Archive
Illumina, Inc. and WuXi PharmaTech (Cayman) Inc., a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, today announced that the WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.
Avantis Medical Systems, Inc., a technology leader in developing novel digital imaging devices, today announced that its Third Eye Panoramic device for colonoscopy has received 510(k) clearance from the U.S. Food & Drug Administration (FDA).
The immune system's killer cells deliver a tightly controlled, 3-phase knockout punch that kills intracellular parasites through a novel pathway that an international team led by researchers from the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital have named "microptosis."
A study by Columbia researchers suggests that cells in the patient's intestine could be coaxed into making insulin, circumventing the need for a stem cell transplant. Until now, stem cell transplants have been seen by many researchers as the ideal way to replace cells lost in type I diabetes and to free patients from insulin injections.
The U.S. Food and Drug Administration's mission to protect and promote public health by ensuring the safety of the nation's food supply, as well as the safety and efficacy of medical products, has always relied on a rigorous analysis of the scientific data available and a strong commitment to safety.
› Verified 1 days ago